PAVmed Closes $13.4 Million Common Stock Registered Direct Offering Priced At-the-Market under Nasdaq Rules Jan 08, 2021 10:53am EST
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules Jan 06, 2021 9:29am EST
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering Dec 22, 2020 12:04pm EST
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering Dec 18, 2020 9:29am EST
PAVmed Reports Third Quarter 2020 Financial Results and Provides Business Update Nov 17, 2020 4:00pm EST
PAVmed to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 15, 2020 Sep 08, 2020 9:30am EDT
